Contact
Next-generation antibiotics inspired by nature
created in Belgium​
Obulytix is set to revolutionize the fight against antimicrobial resistance with its novel phage lysin-based antibiotics. Our team of experts utilizes cutting-edge technology to develop innovative enzyme-based antibiotics that are tailored to the patients needs. Reach out to us for more information.
Suzanne Tassierstraat 1, Unit 3.4 9052 Zwijnaarden, Belgium
@Obulytix
Contact Us
Innovative class of enzyme-based antibiotics
Proprietary technology and platform for lysin development
Experienced team of scientists, pharmaceutical experts and business developers
